BioCentury
ARTICLE | Distillery Therapeutics

Mir690, NADK as targets in insulin resistance

February 23, 2021 11:23 PM UTC

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Diabetes; obesity...

BCIQ Target Profiles

NAD kinase (NADK)